<?xml version="1.0" encoding="UTF-8" ?>
<?xml-stylesheet type="text/xsl" href="http://blog.newsweek.com/utility/FeedStylesheets/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><title>Should You Go Generic? </title><link>http://blog.newsweek.com/blogs/tipsheet/archive/2008/10/04/should-you-go-generic.aspx</link><description>By Mary Carmichael October 13, 2008 A new study says Medicare patients prefer cheap generic drugs only when they’re footing the bill themselves—when government pays, they want brand names. Recent news may shed some light on why: the FDA is investigating</description><dc:language>en</dc:language><generator>CommunityServer 2.1 SP2 (Debug Build: 2.18)</generator><item><title>re: Should You Go Generic? </title><link>http://blog.newsweek.com/blogs/tipsheet/archive/2008/10/04/should-you-go-generic.aspx#750297</link><pubDate>Sun, 26 Oct 2008 20:35:57 GMT</pubDate><guid isPermaLink="false">544c64cf-7058-4151-925a-a0fd041e73dd:750297</guid><dc:creator>lolalaska</dc:creator><description>&lt;p&gt;The key word here is 'probably' not. I am a retired health professional. &amp;nbsp;It is well known in the biz &amp;nbsp;what to trust generic and what not to trust. I would never take or recommend generic thyroid or &amp;nbsp;antibiotics. They are both known to be 'iffy' in their reliability. Given the recent melamine fiasco in China, just how much trust are you willing to put in an overtaxed understaffed system to make sure your overseas meds are 'safe'?&lt;/p&gt;
</description><category>Blog: TipSheet</category></item></channel></rss>